<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04298346</url>
  </required_header>
  <id_info>
    <org_study_id>RC19_0035</org_study_id>
    <nct_id>NCT04298346</nct_id>
  </id_info>
  <brief_title>Neurological Fate, Prematurity and Genetic Susceptibility Factors</brief_title>
  <acronym>GENIMOC</acronym>
  <official_title>GENIMOC : Neurological Fate, Prematurity and Genetic Susceptibility Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study could help identify aggravating or protective genetic polymorphisms associated&#xD;
      with cerebral palsy. Populations of premature babies at different risk of cerebral palsy&#xD;
      could thus be individualized with an impact on their monitoring and on the pathophysiological&#xD;
      understanding of the processes leading to neurological lesions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">March 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 9, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify a polymorphism associated with the risk of developing cerebral palsy at 2 years in a regional population of premature infants of gestational age &lt;34 weeks gestation.</measure>
    <time_frame>2 years</time_frame>
    <description>frequency of variants within the case and control groups using the statistical criterion &quot;level of significance&quot; (also called p-value and known by the English word &quot;p-value&quot;) of 5.10-8</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify a specific polymorphism of certain forms of cerebral palsy</measure>
    <time_frame>2 years</time_frame>
    <description>neurological examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Develop a prognosis algorithm for the occurrence of cerebral palsy for personalized monitoring in a population at risk.</measure>
    <time_frame>2 years</time_frame>
    <description>neurological examination</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1305</enrollment>
  <condition>Polymorphism, Restriction Fragment Length</condition>
  <condition>Premature</condition>
  <condition>Infertility of Cervical Origin</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children born prematurely at term &lt;34 weeks between 2008 and 2015, and presenting with&#xD;
        cerebral palsy at the age of 2 years within the Growing Together Network in Pays de Loire.&#xD;
&#xD;
        Matching by a propensity score to a population of control children with a comparable&#xD;
        probability of developing cerebral palsy but whose examination at 2 years is optimal&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children born prematurely at term &lt;34 weeks between 2008 and 2015&#xD;
&#xD;
          -  assessed at the age of 2 within the Growing Together Network in Pays de Loire&#xD;
&#xD;
          -  parental consent for the collection of data from their child and for intraoral&#xD;
             sampling for the search for genetic factors.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children who died after the age of 2&#xD;
&#xD;
          -  children who refused and / or whose parents refused to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Cyril Flamant, Pr</last_name>
    <phone>0240083483</phone>
    <email>cyril.flamant@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Christophe Roze, Pr</last_name>
    <phone>0240087663</phone>
    <email>jeanchristophe.roze@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Flamant, Pr</last_name>
      <phone>0240083483</phone>
      <email>cyril.flamant@chu-nantes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 2, 2020</study_first_submitted>
  <study_first_submitted_qc>March 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2020</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

